<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ital J Pediatr</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ital J Pediatr</journal-id>
      <journal-title-group>
        <journal-title>Italian Journal of Pediatrics</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1824-7288</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22992471</article-id>
      <article-id pub-id-type="pmc">3485094</article-id>
      <article-id pub-id-type="publisher-id">1824-7288-38-46</article-id>
      <article-id pub-id-type="doi">10.1186/1824-7288-38-46</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Interleukin 12 receptor deficiency in a child with recurrent bronchopneumonia and very high IgE levels</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>Palamaro</surname>
            <given-names>Loredana</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>lory983@libero.it</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Giardino</surname>
            <given-names>Giuliana</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>giu.giardino@hotmail.it</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Santamaria</surname>
            <given-names>Francesca</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>santamar@unina.it</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Romano</surname>
            <given-names>Rosa</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>rosaromano85@hotmail.it</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Fusco</surname>
            <given-names>Anna</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>afusco3@inwind.it</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Montella</surname>
            <given-names>Silvia</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>amina2004@virgilio.it</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Salerno</surname>
            <given-names>Mariacarolina</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>salerno@unina.it</email>
        </contrib>
        <contrib contrib-type="author" id="A8">
          <name>
            <surname>Ursini</surname>
            <given-names>Matilde Valeria</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>matildevaleria.ursini@igb.cnr.it</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A9">
          <name>
            <surname>Pignata</surname>
            <given-names>Claudio</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>pignata@unina.it</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Pediatrics, &#x201C;Federico II&#x201D; University, Naples, Italy</aff>
      <aff id="I2"><label>2</label>International Institute of Genetics and Biophysics, CNR, Naples, Italy</aff>
      <aff id="I3"><label>3</label>Unit of Immunology, Department of Pediatrics, &#x201C;Federico II&#x201D; University, Via S. Pansini 5-80131, Naples, 80127, Italy</aff>
      <pub-date pub-type="collection">
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>9</month>
        <year>2012</year>
      </pub-date>
      <volume>38</volume>
      <fpage>46</fpage>
      <lpage>46</lpage>
      <history>
        <date date-type="received">
          <day>1</day>
          <month>9</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>9</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2012 Palamaro et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <copyright-holder>Palamaro et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.ijponline.net/content/38/1/46"/>
      <abstract>
        <p>Interleukin-12 (IL-12) is involved in cellular immune responses against intracellular pathogens by promoting the generation of T naive in T helper 1 (Th1) cells and by increasing interferon-gamma (IFN-gamma) production from T and natural killer (NK) cells. A defective induction of a Th1 response may lead to a higher risk of infections, and, in particular, infections due to typical and atypical <italic>Mycobacteria</italic>. We report on the case of a girl with suffering from recurrent bronchopneumonia associated with very high serum IgE levels, who exhibited a profound impairment of the Th1 generation associated with a novel mutation in the exon 5 of the IL-12R &#x3B2;1 gene (R156H). Our data suggest that in children with severe and recurrent infections, even in the absence of a mycobacterial infection, functional and/or genetic alterations of the molecular mechanisms governing Th1/Th2 homeostasis might be responsible for an atypical immunodeficiency and, therefore, should be investigated in these patients.</p>
      </abstract>
      <kwd-group>
        <kwd>Immunodeficiency</kwd>
        <kwd>IL-12/IL-12 receptor</kwd>
        <kwd>Recurrent pneumonia</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Primary congenital immunodeficiencies encompass a wide spectrum of distinct clinical entities, which differ in either pathogenetic mechanism or clinical features. Recently, several novel syndromes with unusual phenotypes have been described [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. However, in a number of patients suffering from severe and sometimes life-threatening infections, in which an immunological disorder is suspected, the underlying genetic defect responsible for the immunodeficiency still remains to be elucidated [<xref ref-type="bibr" rid="B3">3</xref>]. Recently, a higher susceptibility to intracellular pathogens and, in particular, atypical mycobacterial and salmonella infections has been described in patients with genetic alterations of the IL-12 receptor (IL-12R) [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B9">9</xref>]. IL-12 stimulates cellular immune responses against intracellular pathogens by promoting the generation of T naive in T helper 1 (Th1) cells and by increasing interferon-gamma (IFN-gamma) production from T and natural killer (NK) cells. Induction of a Th1 response and cell cycle progression mostly relies on the expression of a high affinity IL-12R, consisting of &#x3B2;1 and &#x3B2;2 chains [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B15">15</xref>]. A few genetic alterations of &#x3B2;1 chain have already been reported in patients suffering of mycobacterial infections [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>].</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 8-year-old girl was referred to the our Department because of a history of recurrent pneumonia (4 episodes over 2&#x2009;years). At the age of 4&#x2009;years and 8&#x2009;months she had suffered from the first episode of middle lobar bronchopneumonia requiring hospitalization. In that occasion the total IgE serum levels were 3350 kU/l. One month later, she was hospitalized for a second bronchopneumonia episode interesting both lungs followed by persistent cough for more than a month. These episodes were responsive to antibiotic therapy. Subsequently, she had suffered from 2 additional bronchopneumonia episodes in distinct lung area, successfully treated with parenteral antibiotic therapy. Conventional x-ray and high resolution computed tomography of the chest revealed multiple focal consolidations in both lungs, confirmed by magnetic resonance imaging [<xref ref-type="bibr" rid="B16">16</xref>]. Acid resistant bacillus was not found in the sputum examination. In one occasion, <italic>Haemophilus influenzae</italic> was isolated on sputum culture. Weight and height growth was in the normal range. No infections in other organs were reported. The routine immunological evaluation revealed normal IgG and IgA, but very high serum IgE levels (&gt; 2000&#x2009;kU/l), confirmed in several occasions during the 2&#x2009;years follow-up. Specific IgE toward Dermatophagoides farinae and pteronyss, olive, herb vitriol and Parietaria judaica were detected. Prick test were positive (ponf&#x2009;&gt;&#x2009;0.3&#x2009;&#xD7;&#x2009;0.4&#x2009;cm) for Dermatophagoides farinae and pteronyss, hair of dog, Parietaria and olive, thus confirming a multiple sensitivity. The patient showed a proper antibody specific response as demonstrated by the presence of IgG antibody serum levels, tested by immuno-enzymatic method, against B-hepatitis, parotitis and German measles viruses. Serum IgG, IgA e IgM levels were always in the normal range. The immunophenotype valuation revealed normal number and percentage of the lymphocyte subpopulations studied (Table&#x2009;<xref ref-type="table" rid="T1">1</xref>).</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Immunonological parameters</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left">
                <bold>Lymphocyte subpopulations</bold>
              </th>
              <th align="center">
                <bold>%</bold>
              </th>
              <th align="center">
                <bold>n/mm</bold>
                <sup>
                  <bold>3</bold>
                </sup>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="left" valign="bottom">CD3<hr/></td>
              <td align="center" valign="bottom">77<hr/></td>
              <td align="center" valign="bottom">2.956<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">CD3DR<hr/></td>
              <td align="center" valign="bottom">4.2<hr/></td>
              <td align="center" valign="bottom">161.28<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">CD4<hr/></td>
              <td align="center" valign="bottom">39.3<hr/></td>
              <td align="center" valign="bottom">1509<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">CD8<hr/></td>
              <td align="center" valign="bottom">30.2<hr/></td>
              <td align="center" valign="bottom">1159<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">CD19<hr/></td>
              <td align="center" valign="bottom">11.4<hr/></td>
              <td align="center" valign="bottom">437.76<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">CD56<hr/></td>
              <td align="center" valign="bottom">3.4<hr/></td>
              <td align="center" valign="bottom">130.56<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">CD4-CD8-TCR &#x3B1;/&#x3B2;+<hr/></td>
              <td align="center" valign="bottom">2.3<hr/></td>
              <td align="center" valign="bottom">88.32<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">CD4-CD8-TCR g/d+<hr/></td>
              <td align="center" valign="bottom">2.2<hr/></td>
              <td align="center" valign="bottom">84.48<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">
                <bold>Specific antibody responses</bold>
                <hr/>
              </td>
              <td align="center" valign="bottom">
                <bold>IgG</bold>
                <hr/>
              </td>
              <td align="center" valign="bottom">
                <bold>IgM</bold>
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" valign="bottom">B-hepatitis virus<hr/></td>
              <td align="center" valign="bottom">Present<hr/></td>
              <td align="center" valign="bottom">Absent<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Parotidis virus<hr/></td>
              <td align="center" valign="bottom">Present<hr/></td>
              <td align="center" valign="bottom">Absent<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">German measles virus<hr/></td>
              <td align="center" valign="bottom">Present<hr/></td>
              <td align="center" valign="bottom">Absent<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">
                <bold>Proliferative response to mitogens stimulation</bold>
                <hr/>
              </td>
              <td align="center" valign="bottom">
                <bold>Patient (mean &#xB1; SE)</bold>
                <hr/>
              </td>
              <td align="center" valign="bottom">
                <bold>Control (mean &#xB1; SE)</bold>
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" valign="bottom">PMA + iono<hr/></td>
              <td align="center" valign="bottom" char="&#xB1;">22458&#x2009;&#xB1;&#x2009;11013<hr/></td>
              <td align="center" valign="bottom" char="&#xB1;">32159&#x2009;&#xB1;&#x2009;27858<hr/></td>
            </tr>
            <tr>
              <td align="left">CD3 X-L</td>
              <td align="center">800&#x2009;&#xB1;&#x2009;68</td>
              <td align="center">29500&#x2009;&#xB1;&#x2009;3000</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>The patient&#x2019;s family history was notable for the presence of allergic disorders in both lineages. In particular, her mother and grandmother had a history of allergic rhinitis, while her father had urticaria. A maternal aunt died at 2&#x2009;years of age by whooping-cough and a maternal uncle died at 16&#x2009;months by a severe not better specified respiratory infection. A paternal aunt and her daughter had a history of allergic rhinitis.</p>
      <p>We first determined the proliferative response of PBMC to CD3 cross-linking, that mimics in vivo antigen exposure, performed at optimal (1&#x2009;ng/ml) or suboptimal (0.3&#x2009;ng/ml) antibody concentration. The proliferation at the maximal dosage was significantly lower in the patient than in the controls (mean &#xB1; SE were: 800&#x2009;&#xB1;&#x2009;68&#x2009;cpm and 29500&#x2009;&#xB1;&#x2009;3000&#x2009;cpm in the proband and controls, respectively). Since a proper immune response to pathogens requires a Th1 induction and this process determines up-regulation of the expression of the IL-12R &#x3B2;2 chain, we evaluated mRNA expression of this molecule after mitogen stimulation of PBMC in vitro. No expression of IL-12R &#x3B2;2 transcript was found in patient&#x2019;s cells (Figure&#x2009;<xref ref-type="fig" rid="F1">1</xref>A), differently from the controls. IL-12R &#x3B2;1 was expressed at normal levels (Figure&#x2009;<xref ref-type="fig" rid="F1">1</xref>B).</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>mRNA expression of IL-12R &#x3B2;2 chain after mitogen stimulation of PBMC in vitro.</bold> (<bold>A</bold>) No expression of IL-12R &#x3B2;2 transcript was found in patient&#x2019;s cells, differently from the controls. (<bold>B</bold>) IL-12R &#x3B2;1 was expressed at normal levels.</p>
        </caption>
        <graphic xlink:href="1824-7288-38-46-1"/>
      </fig>
      <p>At molecular level, gene sequencing of IL-12R &#x3B2;2 gene revealed a missense mutation (G to A) at nucleotide 531 in the exon 5 in heterozygosity, resulting in the substitution of arginine (CGT) with histidine (CAT) in the extracellular domain of the receptor at the same aminoacid position 156 (designed R156H) (Figure&#x2009;<xref ref-type="fig" rid="F2">2</xref>). The mutation was not a polymorphism since was not found in 100 chromosomes from unrelated individuals. This G to A transition creates a new restriction site for NdeI enzyme (data not shown).</p>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>gene sequencing of IL-12R &#x3B2;2 gene.</bold> At molecular level, gene sequencing of IL-12R &#x3B2;2 gene revealed a missense mutation (G to A) at nucleotide 531 in the exon 5 in heterozygosity, resulting in the substitution of arginine <bold>(</bold>CGT) with histidine (CAT) in the extracellular domain of the receptor at the same aminoacid position 156 (designed R156H).</p>
        </caption>
        <graphic xlink:href="1824-7288-38-46-2"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>The case here reported indicates that alterations of the induction of a proper Th1 response may be associated with an atypical immunodeficiency characterized by high susceptibility to infections. The functional response of lymphocytes to IL-12 depends on the expression of a high affinity IL-12 receptor on Th1 and NK cells. The high affinity receptor for IL-12 consists of two subunits, &#x3B2;1 and &#x3B2;2, closely related to the cytokine receptor glycoprotein (gp) 130 [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. The complete IL-12R is thought to be associated with the development, being expressed on human naive T cells during differentiation to Th1 but not to Th2. Therefore, the expression of these molecules is generally considered as a marker of Th1 dominated response [<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B16">16</xref>]. Th1 cells produce IFN-gamma and IL-2 and, predominantly, promote cell mediate immune responses against intracellular pathogens [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. In a previous study, we provided evidence of altered IL-12/IL-12R signaling in patients with very high IgE levels, suggestive of an impaired Th1 induction [<xref ref-type="bibr" rid="B20">20</xref>]. A defective induction of a Th1 response in patients may lead to a higher risk of infections, thus worsening the overall outcome of patients with very high IgE levels. In the case herein described a genetic alteration of the IL-12R &#x3B2;1 has been found in heterozygosity. Whether this alteration is really responsible for the phenotype remains to be definitively demonstrated with further molecular and functional studies. However, it should be noted that patients with homozygous alterations of the same gene have already been reported, being affected with a more severe clinical phenotype and selective susceptibility to mycobacterial infections [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. Based on this clinical observation, we suggest that a better understanding of the molecular mechanisms governing Th1/Th2 homeostasis may help recognize novel clinical phenotypes of atypical immunodeficiencies.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent was obtained from the parents of the patient for publication of this Case report and any accompanying images.</p>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>IL-12: Interleukin-12; Th1: T helper 1; IFN-gamma: Interferon-gamma; NK: Natural Killer.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>LP has made substantial contributions to conception and design, has been involved in drafting the manuscript, and has given final approval of the version to be published. GG has made substantial contributions to conception and design, has been involved in drafting the manuscript, and has given final approval of the version to be published. FS has made substantial contributions to conception and design, has been involved in revising the manuscript critically for important intellectual content, and has given final approval of the version to be published. RR and AF has made substantial contributions to acquisition of data, has been involved in drafting the manuscript, and has given final approval of the version to be published. SM has made substantial contributions to acquisition of data, has been involved in revising the manuscript critically for important intellectual content, and has given final approval of the version to be published.</p>
      <p>MVU has made substantial contributions to conception and design and analysis and interpretation of data, has been involved in revising the manuscript critically for important intellectual content, and has given final approval of the version to be published. CP has made substantial contributions to conception and design and analysis and interpretation of data, has been involved in drafting the manuscript and revising it critically for important intellectual content, and has given final approval of the version to be published.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Palamaro</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Vigliano</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Giardino</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Cirillo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Aloj</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Romano</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pignata</surname>
            <given-names>C</given-names>
          </name>
          <article-title>SCID-like phenotype associated with an inhibitory autoreactive immunoglobulin</article-title>
          <source>J Investig Allergol Clin Immunol</source>
          <year>2012</year>
          <volume>22</volume>
          <fpage>67</fpage>
          <lpage>70</lpage>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>De Vries</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Alvarez Cardona</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Abdul Latiff</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Badolato</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Brodszki</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Cant</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Carbone</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Casper</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Ciznar</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cochino</surname>
            <given-names>AV</given-names>
          </name>
          <name>
            <surname>Conley</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Derfalvi</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Driessen</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Elfeky</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Espanol</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Glimour</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Gueseva</surname>
            <given-names>MN</given-names>
          </name>
          <name>
            <surname>Haverkamp</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Helminen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Honig</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kanariou</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Kirschfink</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Klein</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kuijpers</surname>
            <given-names>TW</given-names>
          </name>
          <name>
            <surname>Kutukculer</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Martire</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Meyts</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Niehues</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Pignata</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Reda</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Renner</surname>
            <given-names>ED</given-names>
          </name>
          <name>
            <surname>Rezaei</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Rizzi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sampalo Lainz</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Sargur</surname>
            <given-names>RB</given-names>
          </name>
          <name>
            <surname>Sediva</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Seidel</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Seneviratne</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Soler-Palacin</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Tommasini</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Warnatz</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update</article-title>
          <source>Clin Exp Immunol</source>
          <year>2012</year>
          <volume>167</volume>
          <fpage>108</fpage>
          <lpage>119</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2249.2011.04461.x</pub-id>
          <pub-id pub-id-type="pmid">22132890</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Aloj</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Giardino</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Valentino</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Maio</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Gallo</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Esposito</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Naddei</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Cirillo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Pignata</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Severe combined immunodeficiences: new and old scenarios</article-title>
          <source>Int Rev Immunol</source>
          <year>2012</year>
          <volume>31</volume>
          <fpage>43</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="doi">10.3109/08830185.2011.644607</pub-id>
          <pub-id pub-id-type="pmid">22251007</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Aytekin</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Dogu</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Tuygun</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Tanir</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Guloglu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Boisson-Dupuis</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bustamante</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Feinberg</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Casanova</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Ikinciogullari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Bacille Calmette-Gu&#xE8;rin lymphadenitis and recurrent oral candidiasis in an infant with a new mutation leading to interleukin-12 receptor beta-1 deficiency</article-title>
          <source>J Invest Allergol Clin Immunol</source>
          <year>2011</year>
          <volume>21</volume>
          <fpage>401</fpage>
          <lpage>404</lpage>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pedraza-Sanchez</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Herrera-Barrios</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Aldana-Vergara</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Neumann-Ordoez</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gonzalez-Hernandez</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Sada-D&#xEC;az</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>de Beaucoudrey</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Casanova</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Torres-Rojas</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Bacille Calmette-Gu&#xE8;rin infection and disease with fatal outcome associated with a point mutation in the interleukin-12/interleukin-23 receptor beta-1 chain in two Mexican families</article-title>
          <source>Int J Infect Dis</source>
          <year>2010</year>
          <volume>14</volume>
          <fpage>e256</fpage>
          <lpage>e260</lpage>
          <pub-id pub-id-type="pmid">20171917</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Shah</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>El-Maaytah</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jerjes</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Upile</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ayliffe</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Interleukin 12 receptor beta1 chain deficiency in a child with disseminated tuberculosis: a case report</article-title>
          <source>J Oral Maxillofac Surg</source>
          <year>2010</year>
          <volume>68</volume>
          <fpage>909</fpage>
          <lpage>911</lpage>
          <pub-id pub-id-type="doi">10.1016/j.joms.2009.04.116</pub-id>
          <pub-id pub-id-type="pmid">20307773</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Granados</surname>
            <given-names>EL</given-names>
          </name>
          <name>
            <surname>Porpiglia</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Hogan</surname>
            <given-names>MB</given-names>
          </name>
          <name>
            <surname>Matamoros</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Krasovec</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pignata</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>CIE</given-names>
          </name>
          <name>
            <surname>Hammarstrom</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bjorkander</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Belohradsky</surname>
            <given-names>BH</given-names>
          </name>
          <name>
            <surname>Fontan Casariego</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Garcia Rodriguez</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Conley</surname>
            <given-names>ME</given-names>
          </name>
          <article-title>Clinical and molecular analysis of patients with defects in micro heavy chain gene</article-title>
          <source>J Clin Invest</source>
          <year>2002</year>
          <volume>110</volume>
          <fpage>1029</fpage>
          <lpage>1035</lpage>
          <pub-id pub-id-type="pmid">12370281</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Altare</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Durandy</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lammas</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Emile</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>Lamhamedi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Le Deist</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Drysdale</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Jouanguy</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Doffinger</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bernaudin</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Jeppsson</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Gollob</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Meinl</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Segal</surname>
            <given-names>AW</given-names>
          </name>
          <name>
            <surname>Fischer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kumararatne</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Casanova</surname>
            <given-names>JL</given-names>
          </name>
          <article-title>Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency</article-title>
          <source>Science</source>
          <year>1998</year>
          <volume>280</volume>
          <fpage>1432</fpage>
          <lpage>1435</lpage>
          <pub-id pub-id-type="doi">10.1126/science.280.5368.1432</pub-id>
          <pub-id pub-id-type="pmid">9603732</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sakai</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Matsuoka</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Aoki</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nosaka</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mitsuya</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Missense mutation of the interleukin-12 receptor beta1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection</article-title>
          <source>Blood</source>
          <year>2001</year>
          <volume>97</volume>
          <fpage>2688</fpage>
          <lpage>2694</lpage>
          <pub-id pub-id-type="doi">10.1182/blood.V97.9.2688</pub-id>
          <pub-id pub-id-type="pmid">11313259</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Presky</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Minetti</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Chua</surname>
            <given-names>AO</given-names>
          </name>
          <name>
            <surname>Nabavi</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Gately</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Gubler</surname>
            <given-names>U</given-names>
          </name>
          <article-title>A functional interleukin 12 receptor complex is composed of two &#x3B2;-type cytokine receptor subunits</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1996</year>
          <volume>93</volume>
          <fpage>14002</fpage>
          <lpage>14007</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.93.24.14002</pub-id>
          <pub-id pub-id-type="pmid">8943050</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rogge</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Barberis-Maino</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Biffi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Passini</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Presky</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Gubler</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Sinigaglia</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Selective expression of an interleukin-12 receptor component by human T helper 1 cells</article-title>
          <source>J Exp Med</source>
          <year>1997</year>
          <volume>185</volume>
          <fpage>825</fpage>
          <lpage>831</lpage>
          <pub-id pub-id-type="doi">10.1084/jem.185.5.825</pub-id>
          <pub-id pub-id-type="pmid">9120388</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Szabo</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Dighe</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Gubler</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Murphy</surname>
            <given-names>KM</given-names>
          </name>
          <article-title>Regulation of the interleukin (IL) -12RB2 subunit expression in developing T helper 1 (Th1) and Th2 cells</article-title>
          <source>J Exp Med</source>
          <year>1997</year>
          <volume>185</volume>
          <fpage>817</fpage>
          <lpage>824</lpage>
          <pub-id pub-id-type="doi">10.1084/jem.185.5.817</pub-id>
          <pub-id pub-id-type="pmid">9120387</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gately</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Renzetti</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Magram</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Stern</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Adorini</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Gubler</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Presky</surname>
            <given-names>DH</given-names>
          </name>
          <article-title>The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses</article-title>
          <source>Annu Rev Immunol</source>
          <year>1998</year>
          <volume>16</volume>
          <fpage>495</fpage>
          <lpage>521</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.immunol.16.1.495</pub-id>
          <pub-id pub-id-type="pmid">9597139</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Amorosi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Russo</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Amodio</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Garbi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Vitiello</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Palamaro</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Adriani</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Vigliano</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Pignata</surname>
            <given-names>C</given-names>
          </name>
          <article-title>The cellular amount of the common &#x3B3;-chain influences spontaneous or induced cell proliferation</article-title>
          <source>J Immunol</source>
          <year>2009</year>
          <volume>182</volume>
          <fpage>3304</fpage>
          <lpage>3309</lpage>
          <pub-id pub-id-type="doi">10.4049/jimmunol.0802400</pub-id>
          <pub-id pub-id-type="pmid">19234229</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Vigliano</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Palamaro</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bianchino</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Fusco</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Vitiello</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Grieco</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Romano</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Salvatore</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pignata</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Role of the common g chain in cell cycle progression of human malignant cell lines</article-title>
          <source>Int Immunol</source>
          <year>2012</year>
          <volume>24</volume>
          <fpage>159</fpage>
          <lpage>167</lpage>
          <pub-id pub-id-type="doi">10.1093/intimm/dxr114</pub-id>
          <pub-id pub-id-type="pmid">22223761</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Montella</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Maglione</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bruzzese</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Mollica</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Pignata</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Aloj</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Manna</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Esposito</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mirra</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Santamaria</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Magnetic resonance imaging is an accurate and reliable method to evaluate non-cystic fibrosis paediatric lung disease</article-title>
          <source>Respirology</source>
          <year>2012</year>
          <volume>17</volume>
          <fpage>87</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1440-1843.2011.02067.x</pub-id>
          <pub-id pub-id-type="pmid">21943039</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Presky</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Minetti</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Gillessen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wilkinson</surname>
            <given-names>VL</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Gubler</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Chizzonite</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gately</surname>
            <given-names>MK</given-names>
          </name>
          <article-title>Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex</article-title>
          <source>J Immunol</source>
          <year>1998</year>
          <volume>160</volume>
          <fpage>2174</fpage>
          <lpage>2179</lpage>
          <pub-id pub-id-type="pmid">9498755</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Santoni</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Pedicini</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Castiglione</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Implementation of a regulatory gene network to simulate the TH1/2 differentiation in an agent-based model of hypersensitivity reactions</article-title>
          <source>Bioinformatics</source>
          <year>2008</year>
          <volume>24</volume>
          <fpage>1374</fpage>
          <lpage>1380</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btn135</pub-id>
          <pub-id pub-id-type="pmid">18413328</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Finkelman</surname>
            <given-names>FD</given-names>
          </name>
          <name>
            <surname>Vercelli</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Advances in asthma, allergy mechanisms, and genetics in 2006</article-title>
          <source>J Allergy Clin Immunol</source>
          <year>2007</year>
          <volume>120</volume>
          <fpage>544</fpage>
          <lpage>550</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jaci.2007.05.025</pub-id>
          <pub-id pub-id-type="pmid">17610942</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fusco</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Vigliano</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Palamaro</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cirillo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Aloj</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Piscopo</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Giardino</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Pignata</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Altered signaling through IL-12 receptor in children with very high serum IgE levels</article-title>
          <source>Cell Immunol</source>
          <year>2010</year>
          <volume>265</volume>
          <fpage>74</fpage>
          <lpage>79</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cellimm.2010.07.005</pub-id>
          <pub-id pub-id-type="pmid">20696422</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
